Search Within

Clifford Sung

Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Department of Pathology and Laboratory Medicine (6)
  5. Epidemiology and Biostatistics (4)
  6. GSK Faculty (4)

More Groups

People
  1. Daniel Danila (7)
  2. Howard Scher (7)
  3. Martin Fleisher (6)
  4. Aseem Anand (5)
  5. Margaret Leversha (3)
  6. Nikolaus Schultz (3)

More People

Years
  1. 2014 (1)
  2. 2012 (1)
  3. 2011 (2)
  4. 2010 (2)
  5. 2009 (1)
Publications
  1. Cancer Research (2)
  2. European Urology (2)
  3. Journal of Clinical Oncology (2)
  4. Clinical Chemistry (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Science, Inc. (2)
  4. American Association for Clinical Chemistry (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival
    Journal Article

    Danila, D. C.; Anand, A.; Schultz, N.; Heller, G.; Wan, M.; Sung, C. C.; Dai, C.; Khanin, R.; Fleisher, M.; Lilja, H.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors
    Journal Article

    Mitsiades, N.; Sung, C. C.; Schultz, N.; Danila, D. C.; He, B.; Eedunuri, V. K.; Fleisher, M.; Sander, C.; Sawyers, C. L.; Scher, H. I.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Molecular profiling of circulating tumor cells (CTC) in patients with castrate resistant prostate cancer (CRPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Danila, D. C.; Anand, A.; Sung, C. C.; Leversha, M.; Cao, L.; Fleisher, M.; Scher, H. I.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate
    Journal Article

    Danila, D. C.; Anand, A.; Sung, C. C.; Heller, G.; Leversha, M. A.; Cao, L.; Lilja, H.; Molina, A.; Sawyers, C. L.; Fleisher, M.; more...
    European Urology (2011)

    Fulltext@MSK | Save
  • A gene expression signature associated with sensitivity to the multikinase inhibitor dasatinib: Implications for development of a noninvasive biomarker for personalized therapy based on circulating tumor cell analysis
    Meeting Abstract

    Mitsiades, N.; Antipin, Y.; Reva, B.; Schultz, N.; Danila, D. C.; Sung, C. C.; Anand, A.; Sander, C.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Molecular profiling of circulating tumor cells (CTC) in patients with castrate metastatic prostate cancer (CMPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Danila, D. C.; Anand, A.; Sung, C. C.; Leversha, M.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Molina, A.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Design and validation of a multiplexed gene expression panel to guide treatment selection in prostate cancer (PCa)
    Meeting Abstract

    Rai, A. J.; Danila, D. C.; Sung, C.; Yu, C. T.; Scher, H.; Fleisher, M.
    Clinical Chemistry (2009)

    Fulltext@MSK | Save